Drug Type Autologous CAR-T |
Synonyms ICT-19G1 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Phase 2 | CN | 30 Apr 2018 | |
B-Cell Lymphoma | Phase 2 | CN | 05 Apr 2017 | |
B-Cell Leukemia | Phase 1 | CN | 24 Apr 2018 | |
Acute Lymphoblastic Leukemia | IND Application | CN | 01 Mar 2018 |